Pacific Shuanglin Bio-pharmacy Co., LTD (SHE:000403)

SHE:000403 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Jan 1, 2021
Cash & Equivalents	666.26	1,321	1,429	1,001	885.67	102.83
Trading Asset Securities	752.03	282.7	423.34	422.44	234.21	-
Cash & Short-Term Investments	1,418	1,604	1,853	1,423	1,120	102.83
Cash Growth	-19.38%	-13.43%	30.18%	27.09%	989.09%	-7.32%
Accounts Receivable	538.89	668.99	592.77	891.08	581.12	314.17
Other Receivables	7.39	48.2	42.34	49.71	12.83	5.75
Receivables	546.28	717.19	635.11	940.79	593.95	319.93
Inventory	1,437	1,233	909.37	623.69	738.97	441.76
Prepaid Expenses	-	0.06	0.3	0.14	0	1.76
Other Current Assets	68.4	24.63	28.6	59.12	16.53	6.44
Total Current Assets	3,470	3,579	3,426	3,047	2,469	872.71
Property, Plant & Equipment	2,040	1,999	1,554	1,297	1,103	410.91
Long-Term Investments	6	6	-	-	-	-
Goodwill	2,615	2,615	2,615	2,615	2,615	-
Other Intangible Assets	195.98	200.33	212.59	192.52	200.05	65.46
Long-Term Deferred Tax Assets	30.02	29.43	49.04	49.09	27.35	11.75
Long-Term Deferred Charges	175.21	153.55	79.47	89.7	67.42	36.04
Other Long-Term Assets	665	664.24	694.87	692.81	605.82	282.85
Total Assets	9,197	9,246	8,630	7,982	7,088	1,680
Accounts Payable	185.2	224.26	154.35	158.37	158.7	38.32
Accrued Expenses	23.78	334.84	372.84	373.49	239.21	171.81
Short-Term Debt	297	310.49	250.57	275.1	113.52	332.41
Current Portion of Long-Term Debt	45.52	17.06	21.22	8.63	-	-
Current Portion of Leases	-	5.06	6.67	7.14	7.05	5.28
Current Income Taxes Payable	38.92	19.07	39.72	43.08	24.22	18.31
Current Unearned Revenue	6.73	6.36	10.76	25.91	11.54	5.2
Other Current Liabilities	230.71	39.84	66.06	67.58	88.04	74.19
Total Current Liabilities	827.87	956.97	922.19	959.31	642.29	645.51
Long-Term Debt	294.84	303.22	196.08	52.89	-	20.02
Long-Term Leases	17.2	18.6	21.48	29.59	20.89	22.33
Long-Term Unearned Revenue	26.42	26.84	35.6	40.08	49.24	15.95
Long-Term Deferred Tax Liabilities	14.93	14.13	24.26	30.33	36.52	-
Other Long-Term Liabilities	9	9	9	9	11.14	9
Total Liabilities	1,190	1,329	1,209	1,121	760.07	712.82
Common Stock	731.07	731.07	733	732.39	732.92	492.43
Additional Paid-In Capital	4,758	-	-	4,779	4,779	52.56
Retained Earnings	2,524	2,435	1,946	1,392	846.23	455.3
Treasury Stock	-	-	-43.17	-36.22	-32	-34.98
Comprehensive Income & Other	0.05	4,758	4,793	0.04	-0	-
Total Common Equity	8,014	7,925	7,429	6,868	6,326	965.32
Minority Interest	-7.3	-7.15	-6.79	-6.4	2.07	1.59
Shareholders' Equity	8,006	7,918	7,422	6,861	6,328	966.91
Total Liabilities & Equity	9,197	9,246	8,630	7,982	7,088	1,680
Total Debt	654.56	654.44	496.02	373.36	141.46	380.04
Net Cash (Debt)	763.73	949.39	1,357	1,050	978.42	-277.21
Net Cash Growth	-36.94%	-30.02%	29.22%	7.30%	-	-
Net Cash Per Share	1.04	1.30	1.86	1.44	1.38	-0.57
Filing Date Shares Outstanding	731.07	731.07	730.82	732.39	732.92	732.04
Total Common Shares Outstanding	731.07	731.07	731.03	732.39	732.92	492.43
Working Capital	2,642	2,622	2,504	2,088	1,827	227.2
Book Value Per Share	10.96	10.84	10.16	9.38	8.63	1.96
Tangible Book Value	5,203	5,110	4,601	4,060	3,511	899.86
Tangible Book Value Per Share	7.12	6.99	6.29	5.54	4.79	1.83
Buildings	-	1,180	833.6	701.14	583.25	261.01
Machinery	-	1,184	961.1	920.37	729.45	324.38
Construction In Progress	-	513.36	582.7	385.73	334.38	32.73

Updated Oct 27, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.